Unraveling the protein targets of vancomycin in living S. aureus and E. faecalis cells.
暂无分享,去创建一个
[1] S. Sieber,et al. Protein reactivity of natural product-derived γ-butyrolactones. , 2011, Biochemistry.
[2] C. Arias,et al. Resistance or decreased susceptibility to glycopeptides, daptomycin, and linezolid in methicillin-resistant Staphylococcus aureus. , 2010, Current opinion in pharmacology.
[3] D. Hughes,et al. A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor. , 2010, Nature chemical biology.
[4] Thomas Böttcher,et al. Natural products and their biological targets: proteomic and metabolomic labeling strategies. , 2010, Angewandte Chemie.
[5] T. Stehle,et al. Structural Basis of Cell Wall Cleavage by a Staphylococcal Autolysin , 2010, PLoS pathogens.
[6] S. Sieber,et al. A photolabile linker for the mild and selective cleavage of enriched biomolecules from solid support. , 2009, The Journal of organic chemistry.
[7] Regina Z. Cer,et al. IC50-to-Ki: a web-based tool for converting IC50 to Ki values for inhibitors of enzyme activity and ligand binding , 2009, Nucleic Acids Res..
[8] Matthew D. Smith,et al. Synthesis and convenient functionalization of azide-labeled diacylglycerol analogues for modular access to biologically active lipid probes. , 2008, Bioconjugate chemistry.
[9] S. Sieber,et al. Beta-lactones as privileged structures for the active-site labeling of versatile bacterial enzyme classes. , 2008, Angewandte Chemie.
[10] Jue Chen,et al. Structure, Function, and Evolution of Bacterial ATP-Binding Cassette Systems , 2008, Microbiology and Molecular Biology Reviews.
[11] G. Patti,et al. Vancomycin derivative with damaged D-Ala-D-Ala binding cleft binds to cross-linked peptidoglycan in the cell wall of Staphylococcus aureus. , 2008, Biochemistry.
[12] Georges von Degenfeld,et al. Noninvasive optical imaging of cysteine protease activity using fluorescently quenched activity-based probes. , 2007, Nature chemical biology.
[13] A. Tomasz,et al. Perturbation of Cell Wall Synthesis Suppresses Autolysis in Staphylococcus aureus: Evidence for Coregulation of Cell Wall Synthetic and Hydrolytic Enzymes , 2007, Journal of bacteriology.
[14] M. Maier,et al. Total synthesis of cruentaren A. , 2007, Angewandte Chemie.
[15] B. Cravatt,et al. Mechanism-based profiling of enzyme families. , 2006, Chemical reviews.
[16] F. Götz,et al. Activity of the major staphylococcal autolysin Atl. , 2006, FEMS microbiology letters.
[17] R. Jayaswal,et al. Autolytic Properties of Glycopeptide-Intermediate Staphylococcus aureus Mu50 , 2006, Antimicrobial Agents and Chemotherapy.
[18] Sherry L. Niessen,et al. Proteomic profiling of metalloprotease activities with cocktails of active-site probes , 2006, Nature chemical biology.
[19] A. Tomasz,et al. Inhibition of the Autolytic System by Vancomycin Causes Mimicry of Vancomycin-Intermediate Staphylococcus aureus-Type Resistance, Cell Concentration Dependence of the MIC, and Antibiotic Tolerance in Vancomycin-Susceptible S. aureus , 2006, Antimicrobial Agents and Chemotherapy.
[20] T. Carell,et al. Base pairing and replicative processing of the formamidopyrimidine-dG DNA lesion. , 2005, Journal of the American Chemical Society.
[21] Yoshika Suzawa,et al. Identification and molecular characterization of an N‐acetylmuramyl‐l‐alanine amidase Sle1 involved in cell separation of Staphylococcus aureus , 2005, Molecular microbiology.
[22] C. Walsh,et al. Glycopeptide and lipoglycopeptide antibiotics. , 2005, Chemical reviews.
[23] R. Titball,et al. ATP-Binding Cassette Transporters Are Targets for the Development of Antibacterial Vaccines and Therapies , 2004, Infection and Immunity.
[24] Anna E Speers,et al. Profiling enzyme activities in vivo using click chemistry methods. , 2004, Chemistry & biology.
[25] A. Tomasz,et al. Alterations of Cell Wall Structure and MetabolismAccompany Reduced Susceptibility to Vancomycin in an IsogenicSeries of Clinical Isolates of Staphylococcusaureus , 2003, Journal of bacteriology.
[26] S. Boyle-Vavra,et al. Resistance to Autolysis in Vancomycin-Selected Staphylococcus aureus Isolates Precedes Vancomycin-Intermediate Resistance , 2003, Antimicrobial Agents and Chemotherapy.
[27] Deborah L. Higgins,et al. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. , 2003, Journal of the American Chemical Society.
[28] S. Walker,et al. Vancomycin analogues active against vanA-resistant strains inhibit bacterial transglycosylase without binding substrate , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[29] T. D. Read,et al. Role of Mobile DNA in the Evolution of Vancomycin-Resistant Enterococcus faecalis , 2003, Science.
[30] Anna E Speers,et al. Activity-based protein profiling in vivo using a copper(i)-catalyzed azide-alkyne [3 + 2] cycloaddition. , 2003, Journal of the American Chemical Society.
[31] Luke G Green,et al. A stepwise huisgen cycloaddition process: copper(I)-catalyzed regioselective "ligation" of azides and terminal alkynes. , 2002, Angewandte Chemie.
[32] R. Matthews,et al. Identification of ABC transporters in vancomycin-resistant Enterococcus faecium as potential targets for antibody therapy. , 2002, FEMS immunology and medical microbiology.
[33] Morten Meldal,et al. Peptidotriazoles on solid phase: [1,2,3]-triazoles by regiospecific copper(i)-catalyzed 1,3-dipolar cycloadditions of terminal alkynes to azides. , 2002, The Journal of organic chemistry.
[34] A. Burlingame,et al. Chemical Approaches for Functionally Probing the Proteome* , 2002, Molecular & Cellular Proteomics.
[35] P. Griffin,et al. Direct interaction of a vancomycin derivative with bacterial enzymes involved in cell wall biosynthesis. , 2001, Chemistry & biology.
[36] C. Higgins,et al. Multidrug transport by ATP binding cassette transporters: a proposed two-cylinder engine mechanism. , 2001, Research in microbiology.
[37] K. Hiramatsu,et al. Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. , 1998, The Journal of antimicrobial chemotherapy.
[38] G. Kano,et al. Diastereoselective Photocyclization of N-(p-(2,4,6-Triisopropylbenzoyl)benzoyl)-l- phenylalanine Methyl Ester in the Solid State , 1998 .
[39] A. Tomasz,et al. Inhibition of cell wall turnover and autolysis by vancomycin in a highly vancomycin-resistant mutant of Staphylococcus aureus , 1997, Journal of bacteriology.
[40] J. Griffin,et al. General and Efficient Method for the Solution- and Solid-Phase Synthesis of Vancomycin Carboxamide Derivatives , 1995 .
[41] A. Tomasz,et al. A Staphylococcus aureus autolysin that has an N-acetylmuramoyl-L-alanine amidase domain and an endo-beta-N-acetylglucosaminidase domain: cloning, sequence analysis, and characterization. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] J. Griffin,et al. Catalysis of carbamate hydrolysis by vancomycin and semisynthetic derivatives , 1993 .
[43] J. Sekiguchi,et al. Cloning, sequencing and genetic mapping of a Bacillus subtilis cell wall hydrolase gene. , 1990, Journal of general microbiology.
[44] D. Ayusawa,et al. Pleiotropic phenomena in autolytic enzyme(s) content, flagellation, and simultaneous hyperproduction of extracellular alpha-amylase and protease in a Bacillus subtilis mutant , 1975, Journal of bacteriology.
[45] J. Strominger,et al. LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS. , 1965, Proceedings of the National Academy of Sciences of the United States of America.
[46] L. I. Katzin,et al. Optical Rotatory Dispersion of Some Amino Acids and Criteria of Protein Configuration , 1964 .
[47] M. Sugai. Peptidoglycan hydrolases of theStaphylococci , 1997 .
[48] H. Perkins. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. , 1969, The Biochemical journal.